These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 30409157)

  • 1. Complicated Gitelman syndrome and autoimmune thyroid disease: a case report with a new homozygous mutation in the SLC12A3 gene and literature review.
    Zhou H; Liang X; Qing Y; Meng B; Zhou J; Huang S; Lu S; Huang Z; Yang H; Ma Y; Luo Z
    BMC Endocr Disord; 2018 Nov; 18(1):82. PubMed ID: 30409157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A NOVEL COMPOUND HETEROZYGOUS VARIANT OF SLC12A3 GENE IN A PEDIGREE WITH GITELMAN SYNDROME CO-EXISTENT WITH THYROID DYSFUNCTION.
    Liu S; Ke J; Zhang B; Yu C; Feng Y; Zhao D
    Endocr Pract; 2018 Oct; 24(10):889-893. PubMed ID: 30084681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Analysis of Gitelman Syndrome: Co-existence with Hyperthyroidism in a Two-year-old Boy.
    Yu S; Wang C
    Endocr Metab Immune Disord Drug Targets; 2021; 21(8):1524-1530. PubMed ID: 33121425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gitelman syndrome with Graves' disease leading to rhabdomyolysis: a case report and literature review.
    Xu J; He J; Xu S; Wang R; Peng N; Zhang M
    BMC Nephrol; 2023 May; 24(1):123. PubMed ID: 37131142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of Gitelman Syndrome that Was Difficult to Distinguish from Hypokalemic Periodic Paralysis Caused by Graves' Disease.
    Oba T; Kobayashi S; Nakamura Y; Nagao M; Nozu K; Fukuda I; Iijima K; Sugihara H
    J Nippon Med Sch; 2019 Dec; 86(5):301-306. PubMed ID: 31105122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel homozygous SLC12A3 mutation causing Gitelman syndrome with co-existent autoimmune thyroiditis: a case report and review of the literature.
    Koca O; Alay MT; Murt A; Kalayci Yigin A; Seven M; Bavunoglu I
    CEN Case Rep; 2024 Oct; 13(5):330-338. PubMed ID: 38308744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel SLC12A3 homozygous c2039delG mutation in Gitelman syndrome with hypocalcemia.
    Yang W; Zhao S; Xie Y; Mo Z
    BMC Nephrol; 2018 Dec; 19(1):362. PubMed ID: 30558554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of hypokalemia and proteinuria with a new mutation in the SLC12A3 Gene.
    Chen Q; Wu Y; Zhao J; Jia Y; Wang W
    BMC Nephrol; 2018 Oct; 19(1):275. PubMed ID: 30340552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel SLC12A3 gene mutations and clinical characteristics in two pedigrees with Gitelman syndrome.
    Ying Q; Ye Z; Zhang W; Pan Y; Dai L; Lin K; Feng X; Dong X; He F
    Clin Endocrinol (Oxf); 2023 Nov; 99(5):474-480. PubMed ID: 36562655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent Gitelman Syndrome and Hyperthyroidism: Diagnostic Challenges in a 51-Year-Old Patient.
    Zhang Y; Yu H; Li J; Cheng L
    Am J Case Rep; 2024 Aug; 25():e944909. PubMed ID: 39210578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review and Analysis of Two Gitelman Syndrome Pedigrees Complicated with Proteinuria or Hashimoto's Thyroiditis Caused by Compound Heterozygous
    Zhang JH; Ruan DD; Hu YN; Ruan XL; Zhu YB; Yang X; Wu JB; Lin XF; Luo JW; Tang FQ
    Biomed Res Int; 2021; 2021():9973161. PubMed ID: 34046503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digenetic inheritance of SLC12A3 and CLCNKB genes in a Chinese girl with Gitelman syndrome.
    Kong Y; Xu K; Yuan K; Zhu J; Gu W; Liang L; Wang C
    BMC Pediatr; 2019 Apr; 19(1):114. PubMed ID: 30999883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel homozygous mutation in the solute carrier family 12 member 3 gene in a Chinese family with Gitelman syndrome.
    Zhang Y; Zhang F; Chen D; Lü Q; Tang L; Yang C; Lei M; Tong N
    Braz J Med Biol Res; 2016 Oct; 49(11):e5261. PubMed ID: 27783806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel compound heterozygous variant of the SLC12A3 gene in Gitelman syndrome with diabetes and the choices of the appropriate hypoglycemic drugs: a case report.
    Liu Z; Wang S; Zhang R; Wang C; Lu J; Shao L
    BMC Med Genomics; 2021 Aug; 14(1):198. PubMed ID: 34348722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gitelman syndrome with normocalciuria - a case report.
    Flisiński M; Skalska E; Mączyńska B; Butt-Hussaim N; Sobczyńska-Tomaszewska A; Haus O; Manitius J
    BMC Nephrol; 2022 May; 23(1):170. PubMed ID: 35509038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and genetic analysis of a case of Gitelman syndrome accompanied with Graves disease and adrenocortical adenoma: A case report.
    Qiao Y; Zhao J; Wu J; Cao L; Song G; Mao J
    Medicine (Baltimore); 2024 Apr; 103(15):e37770. PubMed ID: 38608089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gitelman syndrome in a South African family presenting with hypokalaemia and unusual food cravings.
    van der Merwe PD; Rensburg MA; Haylett WL; Bardien S; Davids MR
    BMC Nephrol; 2017 Jan; 18(1):38. PubMed ID: 28125972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case report of Gitelman syndrome in children.
    Ying J; Wu H; Zhang R; Wu P; Sui F; Li Z
    Medicine (Baltimore); 2023 Apr; 102(15):e33509. PubMed ID: 37058043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mutation in the SLC12A3 gene in a Sri Lankan family with Gitelman syndrome & coexistent diabetes: a case report.
    Subasinghe CJ; Sirisena ND; Herath C; Berge KE; Leren TP; Bulugahapitiya U; Dissanayake VHW
    BMC Nephrol; 2017 Apr; 18(1):140. PubMed ID: 28446151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of compound mutations of SLC12A3 gene in a Chinese pedigree with Gitelman syndrome exhibiting Bartter syndrome-liked phenotypes.
    Dong B; Chen Y; Liu X; Wang Y; Wang F; Zhao Y; Sun X; Zhao W
    BMC Nephrol; 2020 Aug; 21(1):328. PubMed ID: 32758178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.